What's in PDC*line Pharma SAS's pipeline?

PDC*line Pharma SAS has 3 drugs in our index: 0 marketed, 0 filed, 0 in Phase 3, 1 in Phase 2, 2 in Phase 1.

Which companies overlap with PDC*line Pharma SAS's portfolio?

Top competitors by shared drug class: Assistance Publique - Hôpitaux de Paris, Brenda Cooper, MD, Bristol-Myers Squibb, EMS, GERCOR - Multidisciplinary Oncology Cooperative Group.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/pdc-line-pharma-sas.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-06-10 · How we verify

PDC*line Pharma SAS — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

PDC*line Pharma SAS pipeline: 0 marketed, 0 filed, 0 Phase 3, 1 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 0 Phase 3 1 Phase 2 2 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

No leading-phase drugs tracked for this sponsor.

Therapeutic area mix

Oncology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Assistance Publique - Hôpitaux de Paris · 1 shared drug class
Brenda Cooper, MD · 1 shared drug class
Bristol-Myers Squibb · 1 shared drug class
EMS · 1 shared drug class
GERCOR - Multidisciplinary Oncology Cooperative Group · 1 shared drug class
Glycotope GmbH · 1 shared drug class
Grace Therapeutics Inc. · 1 shared drug class
Ahn-Gook Pharmaceuticals Co.,Ltd · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for PDC*line Pharma SAS:

Cite this brief

Drug Landscape (2026). PDC*line Pharma SAS — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/pdc-line-pharma-sas. Accessed 2026-06-10.